Why the study?
Does adenylate kinase-catalyzed phosphotransfer compensate for impaired intracellular energy flux in the failing heart?
Population
Isolated mitochondria/actomyosin system and intact myocardium (normal and pacing-induced failing heart models)
Comparison
Assessment of adenylate kinase-catalyzed… vs Normal hearts vs. pacing-induced failing hearts
Design
Preclinical
Authors
Loading...
May support adenylate kinase compensation in failing hearts; leaves open human relevance and therapeutic targeting.
Does adenylate kinase-catalyzed phosphotransfer compensate for impaired intracellular energy flux in the failing heart?
Adenylate kinase acts as a compensatory mechanism for intracellular energy flux in the failing heart, increasing its contribution to ATP turnover as creatine kinase activity declines.
Dzeja et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: